Pharmacokinetics, Safety, and Efficacy of Posaconazole in Patients with Persistent Febrile Neutropenia or Refractory Invasive Fungal Infection

The pharmacokinetic profiles, safety, and efficacies of different dosing schedules of posaconazole oral suspension in patients with possible, probable, and proven refractory invasive fungal infection (rIFI) or febrile neutropenia (FN) were evaluated in a multicenter, open-label, parallel-group study...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Ullmann, A. J., Cornely, O. A., Burchardt, A., Hachem, R., Kontoyiannis, D. P., Töpelt, K., Courtney, R., Wexler, D., Krishna, G., Martinho, M., Corcoran, G., Raad, I.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2006
Ämnen:
Clinical Therapeutics
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1366875/
https://ncbi.nlm.nih.gov/pubmed/16436724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.50.2.658-666.2006
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk